Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Biotechnology · India · 2025-02-26

Processing Time
289 days
Decision Date
2025-02-26
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's work addresses pressing challenges in cancer treatment and precision medicine, which are of significant national importance to U.S. healthcare.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and history of funding from the NIH demonstrate she is well-positioned to advance her research.

3 Balance of Interests Met

Given the petitioner's unique contributions to oncology and the global interest in her findings, it was determined that waiving the labor certification requirement benefits the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. and scientific productivity, including 6 peer-reviewed journal articles, 2 book chapters, and 92 citations. Additionally, she completed 35 peer reviews and secured funding from major institutions like the NIH and NSFC, satisfying the Dhanasar prongs for national interest.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Research Scientist

Healthcare · Vietnam

WeGreened EB-2 (NIW) rfe approved
297 days 2025-01-11
The petitioner proposes to continue her research in medical science by investigating molecular pathways involved in tumor proliferation. Her work focuses on developing targeted inhibitors and antibodies designed to slow or prevent cancer progression and improve patient monitoring in clinical settings.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 289 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist